Finance
UK's Oxford Nanopore shares fall on medium-term revenue target cut
Published by Global Banking & Finance Review®
Posted on March 2, 2026
2 min readLast updated: March 2, 2026
Quick Summary
UK biotech Oxford Nanopore Technologies saw its shares tumble nearly 12% to 117.4 pence on Monday, March 2, after the firm lowered its medium‑term revenue growth targets.
UK's Oxford Nanopore shares fall on medium-term revenue growth forecast cut
Oxford Nanopore Technologies Revenue Growth and Market Challenges
Share Price Reaction
March 2 (Reuters) - Oxford Nanopore Technologies shares fell nearly 13% on Monday after the British biotech firm lowered its medium-term revenue growth target due to U.S. National Institute of Health budget constraints and challenges in the China market.
Revised Revenue Growth Forecast
The firm said it now expects its fiscal 2027 revenue to grow broadly between 21% and 25% on a constant currency basis, down from the more than 30% it had forecast until 2027.
Analyst Response
Analysts at Berenberg said the cut to medium-term revenue growth target has prompted them to lower their estimates.
Potential for Recovery
"We can... still see a path to Oxford Nanopore growing well above our revised forecasts in the medium-term should conditions in China improve, US National Institutes of Health budget constraints reduce," Berenberg analyst Sam England said in a note.
Financial Performance Overview
Shares in Oxford Nanopore, which said its 2026 revenue growth will also be between 21% and 25%, were down 12.8% at 116 pence, as of 0904 GMT.
The firm reported fiscal 2025 adjusted core loss of 86.7 million pounds ($115.58 million), smaller than the prior year's loss of 117.9 million pounds on a 24.2% jump in revenue on a constant currency basis.
($1 = 0.7501 pounds)
(Reporting by Prerna Bedi in Bengaluru; Editing by Subhranshu Sahu)
Key Takeaways
- •Oxford Nanopore trimmed its medium‑term revenue growth ambition—previously over 30% CAGR—prompting investor concern amidst a broader macroeconomic slowdown in biotech, impacting expectations for profitability timeline (thetimes.co.uk)
- •Despite reaffirming targets of adjusted EBITDA breakeven in 2027 and cash‑flow positivity in 2028, analysts have grown cautious due to funding pressures, competition, and reduced instrumentation orders (thetimes.co.uk)
- •The stock drop follows earlier strong performance—2025 revenue growth topped guidance at around 24% constant‑currency to £223–224 million, with broad‑based gains across regions and end markets—underscoring that the target cut reflects tempered future outlook rather than immediate earnings weakness (morningstar.com)
References
Frequently Asked Questions about UK's Oxford Nanopore shares fall on medium-term revenue target cut
1Why did Oxford Nanopore shares fall nearly 12%?
Oxford Nanopore shares dropped after the company lowered its medium-term revenue growth target.
2What is the new price of Oxford Nanopore shares after the drop?
Following the decline, Oxford Nanopore shares were trading at 117.4 pence.
3When did Oxford Nanopore announce the revenue target cut?
The announcement was reported on March 2.
4How much did Oxford Nanopore shares fall by percentage?
Oxford Nanopore shares fell by approximately 11.6%.
